A Phase II, Multi-Center, Randomized, Parallel Group, Double Blind, Methotrexate, Controlled Study to Assess the Clinical Efficacy, Safety, And Tolerability of CH-4051 in Patients with Active Rheumatoid Arthritis who have shown an Inadequate Response to Methotrexate Monotherapy

Principal Investigator(s)

C. Michael Franklin, M.D. (Sub-Investigator)

Charles H. Pritchard, M.D. (Sub-Investigator)

Mark Lopatin, M.D. (Sub-Investigator)

David J. Chesner, D.O. (Sub-Investigator)

Elana R. Eisner, M.D. (Sub-Investigator)

Marguerite L. McGarvey, M.D.

Dennis A. Jerdan, M.D. (Sub-Investigator)

Clinical Trial Categories

• Arthritis

Contact

Sue Falbo at 215-657-9977